Jennifer R Bellon

6PUBLICATIONS
81CO-AUTHORS
Immunogenetics (incl. genetic immunology)Tumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 16, 2025
Clinicogenomic Characterization of Inflammatory Breast Cancer.

Nolan Priedigkeit, Beth Harrison, Robert Shue

|Jul 11, 2024
Individualized Local Recurrence Estimates for Ductal Carcinoma In Situ.

Laura E G Warren, Jennifer R Bellon

|Jan 19, 2022
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.

Jonathan H Shepherd, Karla Ballman, Mei-Yin C Polley

|Oct 06, 2021
Should Everyone With Ductal Carcinoma in Situ Receive Adjuvant Radiation?

Laura E G Warren, Jennifer R Bellon

Pageof 1